Marsh & McLennan Companies, Inc. (NYSE:MRSH - Free Report) - DOWLING & PARTN issued their FY2026 earnings per share estimates for Marsh & McLennan Companies in a research note issued on Wednesday, May 20th. DOWLING & PARTN analyst J. Christiana expects that the financial services provider will post earnings of $10.50 per share for the year. The consensus estimate for Marsh & McLennan Companies' current full-year earnings is $10.37 per share. DOWLING & PARTN also issued estimates for Marsh & McLennan Companies' FY2027 earnings at $11.50 EPS.
MRSH has been the subject of several other reports. Cantor Fitzgerald lifted their price target on Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an "overweight" rating in a research report on Monday, February 2nd. Weiss Ratings cut Marsh & McLennan Companies from a "hold (c)" rating to a "hold (c-)" rating in a research report on Monday, May 11th. Morgan Stanley decreased their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an "equal weight" rating on the stock in a research report on Monday, April 6th. Mizuho decreased their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a "neutral" rating on the stock in a research report on Monday, April 13th. Finally, Barclays decreased their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $203.56.
Read Our Latest Analysis on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Up 0.1%
Shares of MRSH stock opened at $160.70 on Thursday. The stock has a 50 day moving average of $166.27 and a 200 day moving average of $172.72. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28. The stock has a market cap of $77.63 billion, a P/E ratio of 20.09, a P/E/G ratio of 2.36 and a beta of 0.65. Marsh & McLennan Companies has a twelve month low of $158.16 and a twelve month high of $235.78.
Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. The company had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company's quarterly revenue was up 7.6% compared to the same quarter last year.
Institutional Trading of Marsh & McLennan Companies
Several large investors have recently added to or reduced their stakes in the stock. Numerai GP LLC increased its position in Marsh & McLennan Companies by 966.2% during the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider's stock worth $7,501,000 after buying an additional 33,729 shares during the period. Swiss Life Asset Management Ltd increased its position in Marsh & McLennan Companies by 9.5% during the fourth quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider's stock worth $24,960,000 after buying an additional 11,648 shares during the period. Rockland Trust Co. increased its position in Marsh & McLennan Companies by 801.6% during the third quarter. Rockland Trust Co. now owns 12,073 shares of the financial services provider's stock worth $2,433,000 after buying an additional 10,734 shares during the period. Barclays PLC increased its position in Marsh & McLennan Companies by 41.7% during the third quarter. Barclays PLC now owns 2,202,372 shares of the financial services provider's stock worth $443,844,000 after buying an additional 647,987 shares during the period. Finally, Bridges Investment Management Inc. increased its position in Marsh & McLennan Companies by 4.4% during the third quarter. Bridges Investment Management Inc. now owns 76,196 shares of the financial services provider's stock worth $15,356,000 after buying an additional 3,177 shares during the period. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the company's stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $21,411,456.30. This represents a 12.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.38% of the stock is currently owned by insiders.
Marsh & McLennan Companies Company Profile
(
Get Free Report)
Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.